Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about ImmunoGen Inc
Recent news which mentions ImmunoGen Inc
Cramer's Lighting Round: Arm is 'one you want to own'
January 05, 2024
Tags
Micron Technology Inc
Markets
Mad Money
From
CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
January 05, 2024
Tags
Roche Holding AG
Business News
stocks
From
CNBC.com News
5 things to know before the stock market opens Thursday
December 07, 2023
Tags
JPMORGAN DRN
Business News
ImmunoGen Inc
From
CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
November 30, 2023
Tags
Biotech and Pharmaceuticals
Breaking news
Pharmaceuticals
From
CNBC.com News
Cramer's Lightning Round: Sell Immunogen and take the gain
June 09, 2023
Tags
Markets
Mad Money
Southern Co
From
CNBC.com News
Stocks making the biggest moves midday: Palo Alto Networks, 3M, Amedisys, Target and more
June 05, 2023
Tags
Option Care Health Inc
Epam Systems Inc
3M Co
From
CNBC.com News
Stocks making the biggest moves midday: CVS Health, Eli Lilly, Clorox, Yum and more
May 03, 2023
Tags
Advanced Micro Devices Inc
ImmunoGen Inc
Breaking News: Markets
From
CNBC.com News
Stocks making the biggest moves midday: Netflix, Cal-Maine Foods, Southwest and more
December 29, 2022
Tags
Lockheed Martin Corp
Breaking news
Netflix Inc
From
CNBC.com News
Stocks making the biggest moves premarket: Tesla, Cal-Maine, Southwest and others
December 29, 2022
Tags
stocks
Business
Southwest Airlines Co
From
CNBC.com News
Cramer's lightning round: I still see another bad quarter ahead for Ford Motor
November 22, 2022
Tags
ImmunoGen Inc
stocks
Business
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.